Advertisement

Topics

Top five promising drugs Phase II (February 2014)

05:58 EDT 22nd September 2017 | BioPortfolio

THE FIVE MOST PROMISING DRUGS ENTERING PHASE II TRIALS February 2014

Drug Disease Company
RXI-109 Scar tissue RXi Pharmaceuticals
GKT137831 Diabetic nephropathy GenKyoTex
CERC-301 Depression Cerecor
SP-333 Constipation Synergy Pharmaceuticals
SAN-300 Rheumatoid arthritis Salix Pharmaceuticals Ltd.

 

 

 

 

 

Source: Thomson Reuters Cortellis Competitive Intelligence.

Quick Search
Advertisement
 

review and buy Top five promising drugs Phase II (February 2014) market research data and corporate reports here